Evidence map›Paper›PMID 42726542›Full record

ArticleNanomaterials (Basel, Switzerland)2026

Antiviral Potential of Green-Synthesized Zinc Oxide and Copper Oxide Nanoparticles: Integrated In Vitro and In Silico Study.

Atef S Elgebaly, Yasmin Adel Elmahdy, Mujtaba Farooq Rana, Reem Mohammed Abdelrahman, Marwa M Khalifa, Ehab Darwish, Ayman K Ismail, Khamael M Abualnaja, Mohamed Shaalan, Ahmed Mahdy

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Atef S ElgebalyPharmacognosy Department, Faculty of Pharmacy, Ahram Canadian University, Giza 12573, Egypt.
Yasmin Adel ElmahdyClinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Cairo 11956, Egypt.
Mujtaba Farooq RanaDepartment of Biochemistry, College of Medicine, Taif University, Taif 26571, Saudi Arabia.
Reem Mohammed AbdelrahmanMicrobiology and Immunology Department, Faculty of Medicine, Helwan University, Cairo 11795, Egypt.
Marwa M KhalifaDepartment of Microbiology and Immunology, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt.ORCID 0009-0009-2562-4710
Ehab DarwishInternal Medicine Department, College of Medicine, King Faisal University, Al-Ahsa 36362, Saudi Arabia.ORCID 0000-0001-5063-2792
Ayman K IsmailDepartment of Forensic Medicine and Toxicology, College of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt.
Khamael M AbualnajaDepartment of Chemistry, College of Science, Taif University, Taif 21944, Saudi Arabia.
Mohamed ShaalanDepartment of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt.ORCID 0000-0002-0741-3954
Ahmed MahdyMolecular Biology and Biotechnology Department, School of Biotechnology, Badr University in Cairo (BUC), Cairo 11829, Egypt.ORCID 0009-0003-3487-1971

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viral infections such as human papillomavirus, rotavirus, and cytomegalovirus continue to pose significant global health challenges, causing persistent and widespread disease. The objective of this study is to evaluate the preliminary in vitro antiviral and cytotoxicity profile of zinc oxide (ZnO) and copper oxide (CuO) nanoparticles, which were synthesized through a green approach using

Indexed as

antiviral activityBoltz-2copper oxide nanoparticles (CuO-NPs)cytomegalovirus (CMV)dockinggreen synthesisHPV (human papillomavirus)MD simulationrotavirus (ROTA)zinc oxide nanoparticles (ZnO-NPs)

Identifiers

PMID42726542
PMCPMC13567136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.